Publications
- Transurethral resection of bladder cancer with or without fluorescence2023 | Second Faculty of Medicine
- T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum2022 | First Faculty of Medicine, Second Faculty of Medicine
- Re: Bladder Cancer Therapy Using a Conformationally Fluid Tumoricidal Peptide Complex Editorial Comment2022 | Second Faculty of Medicine
- Management of BCG failure in non-muscle-invasive bladder cancer - the present and the future2022 | Second Faculty of Medicine
- Prognostic factors of early second transurethral resection of non-muscle invasive bladder cancer - 10 years of experience of a referral center2022 | Second Faculty of Medicine
- European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel2021 | First Faculty of Medicine, Second Faculty of Medicine
- Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex2021 | Second Faculty of Medicine, Central Library of Charles University
- Expression of cancer stem cells markers in urinary bladder urothelial carcinoma and its precursor lesions2021 | Second Faculty of Medicine
- Morbidity and mortality after open radical cystectomy and ileal diversion - 10 years experience and a comprehensive assessment in a single tertiary center2021 | Second Faculty of Medicine
- Symptoms of bladder tumors2021 | Second Faculty of Medicine
Loading network view...